Aesculap Implant Systems of Center Valley, Penn., received FDA 510k clearance for the A-FIX Spinal System, a stand-alone interbody spinal fusion device, according to a company news release.
The system was designed for the anterior surgical approach to spinal fusion procedures at one or two continuous levels in the lumbar spine from L2 to S1. The system should be used with patients suffering from degenerative disc disease with up to Grade 1 spondylolisthesis.
Read the release on Aesculap A-FIX Spinal System.
Read more coverage on Aesculap:
- Aesculap Launches New Pedicle Screw System
- Aesculap Implant System Launches Spyder MIS Retractor System
- 26 Orthopedic and Spine Devices Receive FDA Clearance in July
The system was designed for the anterior surgical approach to spinal fusion procedures at one or two continuous levels in the lumbar spine from L2 to S1. The system should be used with patients suffering from degenerative disc disease with up to Grade 1 spondylolisthesis.
Read the release on Aesculap A-FIX Spinal System.
Read more coverage on Aesculap:
- Aesculap Launches New Pedicle Screw System
- Aesculap Implant System Launches Spyder MIS Retractor System
- 26 Orthopedic and Spine Devices Receive FDA Clearance in July